The International Quality Assessment Scheme for Vitamin D metabolites (DEQAS) was introduced in 1989. Initially, the aim was to improve the reliability of 25-hydroxyvitamin D (25-OHD) assays but the scheme was extended in 1997 to include 1,25-dihydroxyvitamin D (1,25(OH)2D). DEQAS has 95 members in 18 countries (January 2003). Five serum samples are distributed quarterly and participants are given up to 6 weeks to return their results for statistical analysis. The majority of participants use commercial kits for both analytes. A performance target was set by an advisory panel in 1997 and, at present, requires participants to get 80% or more of their results within ±30% of the All-Laboratory Trimmed Mean (ALTM). The performance targets are under continual review. In 2003, 59% of participants met the target (cf. 52% in 2000). A questionnaire, distributed in January 2003, requested information on methods and the interpretation of results. Reference ranges varied but there was reasonable agreement on the 25-OHD concentrations below which Vitamin D supplementation was advised. A minority (22%) of respondents was unsure whether Vitamin D3 or Vitamin D2 was used to treat patients in their locality. The majority (52%) of assays for 1,25(OH)2D were done 'on demand' and others for apparently spurious reasons. Most respondents thought participation in DEQAS extremely important and the planned introduction of on-line reporting should enhance its value. © 2004 Elsevier Ltd. All rights reserved.
CITATION STYLE
Carter, G. D., Carter, C. R., Gunter, E., Jones, J., Jones, G., Makin, H. L. J., & Sufi, S. (2004). Measurement of Vitamin D metabolites: An international perspective on methodology and clinical interpretation. In Journal of Steroid Biochemistry and Molecular Biology (Vol. 89–90, pp. 467–471). https://doi.org/10.1016/j.jsbmb.2004.03.055
Mendeley helps you to discover research relevant for your work.